An anxiety-like phenotype in mice selectively bred for aggression.

Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci (2010) 1.18

Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat Commun (2016) 0.97

Role of the vasopressin 1b receptor in rodent aggressive behavior and synaptic plasticity in hippocampal area CA2. Mol Psychiatry (2014) 0.94

The clinical implications of mouse models of enhanced anxiety. Future Neurol (2011) 0.89

Raphe serotonin neuron-specific oxytocin receptor knockout reduces aggression without affecting anxiety-like behavior in male mice only. Genes Brain Behav (2015) 0.83

Genetic mapping of canine fear and aggression. BMC Genomics (2016) 0.78

Anti-aggressive effects of neuropeptide S independent of anxiolysis in male rats. Front Behav Neurosci (2014) 0.76

Respiratory and behavioral dysfunction following loss of the GABAA receptor α4 subunit. Brain Behav (2013) 0.76

Effects of Long-Term Environmental Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression in C57BL6 Mice. Front Mol Neurosci (2016) 0.76

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53

The amygdaloid complex: anatomy and physiology. Physiol Rev (2003) 5.22

Dissociated neural representations of intensity and valence in human olfaction. Nat Neurosci (2003) 5.20

Molecular and neuronal substrate for the selective attenuation of anxiety. Science (2000) 5.07

Dysfunction in the neural circuitry of emotion regulation--a possible prelude to violence. Science (2000) 4.86

Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature (1989) 4.45

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature (1999) 4.36

Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15

The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov (2005) 3.80

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav (1980) 3.69

Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry (2002) 3.68

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci (1999) 3.36

Borderline personality disorder. Lancet (2004) 3.32

The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry (2002) 2.75

Information coding in the vertebrate olfactory system. Annu Rev Neurosci (1996) 2.41

Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol (2004) 2.38

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) (1994) 2.33

Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A (1995) 2.19

Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav (1988) 2.17

GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience (1987) 2.07

Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor. Nature (1993) 1.93

Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry (1990) 1.84

Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl) (2002) 1.73

The mouse: genetics meets behaviour. Nat Rev Genet (2002) 1.62

Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits. FEBS Lett (1998) 1.60

Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res (2004) 1.52

Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev (2005) 1.50

Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci (2007) 1.45

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry (1998) 1.42

Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology (2005) 1.39

Structure and subunit composition of GABA(A) receptors. Neurochem Int (1999) 1.39

Interpersonal violence and its correlates in Vietnam veterans with chronic posttraumatic stress disorder. J Clin Psychol (1997) 1.24

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry (2000) 1.20

Analysis of violent behavior in Vietnam combat veteran psychiatric inpatients with posttraumatic stress disorder. J Trauma Stress (1999) 1.18

SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry (2000) 1.15

Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev (1985) 1.14

Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry (2004) 1.11

On the benzodiazepine binding pocket in GABAA receptors. J Biol Chem (2003) 1.09

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry (1998) 1.05

Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects. Am J Psychiatry (1996) 0.97

Aggressive behavior in combat veterans with post-traumatic stress disorder. Mil Med (2001) 0.97

Alterations in brain activation in posttraumatic stress disorder patients with severe hyperarousal symptoms and impulsive aggressiveness. Eur Arch Psychiatry Clin Neurosci (2003) 0.90

A developmental-genetic analysis of aggressive behavior in mice: I. Behavioral outcomes. J Comp Psychol (1983) 0.87

Interindividual variability in Swiss male mice: relationship between social factors, aggression, and anxiety. Physiol Behav (1998) 0.86

D1 dopamine receptor mediation of social and nonsocial emotional reactivity in mice: effects of housing and strain difference in motor activity. Behav Neurosci (1997) 0.84

The effects of benzodiazepines on aggression: reduced or increased? Psychopharmacologia (1973) 0.83

Benzodiazepine and serotonergic modulation of antipredator and conspecific defense. Neurosci Biobehav Rev (1998) 0.83

GABAA-receptors: drug binding profile and distribution of receptors containing the alpha 2-subunit in situ. J Recept Res (1993) 0.80

Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety. Neuropsychopharmacology (2004) 0.79

Increased GABAA-dependent chloride uptake in mice selectively bred for low aggressive behavior. Psychopharmacology (Berl) (1992) 0.77

D1 dopamine receptors and the reversal of isolation-induced behaviors in mice. Behav Brain Res (1998) 0.77

Concentration-dependent metabolism of diazepam in mouse liver. J Pharmacokinet Biopharm (1995) 0.77

A developmental-genetic analysis of aggressive behavior in mice (Mus musculus): III. Behavioral mediation by heightened reactivity or immobility? J Comp Psychol (1988) 0.77

Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology (Berl) (1999) 0.76

Exploratory behavior in mice selectively bred for developmental differences in aggressive behavior. Dev Psychobiol (2008) 0.76

The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature (2007) 4.59

Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res (2006) 4.15

Automated design of ligands to polypharmacological profiles. Nature (2012) 3.54

Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 2.90

4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys (2007) 2.80

Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 2.76

A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell (2008) 2.76

Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron (2011) 2.71

Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nat Cell Biol (2004) 2.63

Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol (2007) 2.57

Study on nanometric cutting of germanium by molecular dynamics simulation. Nanoscale Res Lett (2013) 2.48

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet (2011) 2.38

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res (2009) 2.32

Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res (2009) 2.31

Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 2.23

Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (2006) 2.19

MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat Neurosci (2010) 2.19

Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16

Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc Natl Acad Sci U S A (2010) 2.06

VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J Cell Biol (2002) 2.06

Structural insights into the activity of enhancer-binding proteins. Science (2005) 2.04

Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron (2003) 2.03

A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives. Bioorg Med Chem Lett (2005) 2.01

Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron (2006) 1.98

The crystal structure of murine p97/VCP at 3.6A. J Struct Biol (2003) 1.98

Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A (2011) 1.98

p37 is a p97 adaptor required for Golgi and ER biogenesis in interphase and at the end of mitosis. Dev Cell (2006) 1.95

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2010) 1.90

Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci (2006) 1.88

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology (2007) 1.83

Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev (2004) 1.76

Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci (2004) 1.72

Robust optimization of intensity modulated proton therapy. Med Phys (2012) 1.72

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res (2008) 1.70

RNA polymerase and transcription elongation factor Spt4/5 complex structure. Proc Natl Acad Sci U S A (2010) 1.70

ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory. Mol Cell Biol (2004) 1.70

Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J (2004) 1.68

Insights into adaptor binding to the AAA protein p97. Biochem Soc Trans (2008) 1.66

Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.63

Going through the motions: the ATPase cycle of p97. J Struct Biol (2006) 1.61

Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys (2008) 1.56

Modus operandi of the bacterial RNA polymerase containing the sigma54 promoter-specificity factor. Mol Microbiol (2008) 1.56

Crystal structures of multidrug binding protein TtgR in complex with antibiotics and plant antimicrobials. J Mol Biol (2007) 1.55

Hadoop-GIS: A High Performance Spatial Data Warehousing System over MapReduce. Proceedings VLDB Endowment (2013) 1.55

Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res (2004) 1.52

Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys (2005) 1.49

Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J (2006) 1.48

Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther (2010) 1.48

Structure of the whole cytosolic region of ATP-dependent protease FtsH. Mol Cell (2006) 1.46

The ATP hydrolyzing transcription activator phage shock protein F of Escherichia coli: identifying a surface that binds sigma 54. Proc Natl Acad Sci U S A (2003) 1.45

Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci (2007) 1.45

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One (2011) 1.44

Bacterial enhancer-binding proteins: unlocking sigma54-dependent gene transcription. Curr Opin Struct Biol (2006) 1.40

Structural basis of the nucleotide driven conformational changes in the AAA+ domain of transcription activator PspF. J Mol Biol (2006) 1.40

Organization of an activator-bound RNA polymerase holoenzyme. Mol Cell (2008) 1.39

Accelerating Pathology Image Data Cross-Comparison on CPU-GPU Hybrid Systems. Proceedings VLDB Endowment (2012) 1.39

Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology (2005) 1.39

Structures and organisation of AAA+ enhancer binding proteins in transcriptional activation. J Struct Biol (2006) 1.36

Motions and negative cooperativity between p97 domains revealed by cryo-electron microscopy and quantised elastic deformational model. J Mol Biol (2003) 1.36

Analysis of nucleotide binding to P97 reveals the properties of a tandem AAA hexameric ATPase. J Biol Chem (2008) 1.36

Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology (2012) 1.34

The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology (2004) 1.33

The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J Biol Chem (2012) 1.32

Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol (2005) 1.31

Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron (2009) 1.31

Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T. Proc Natl Acad Sci U S A (2010) 1.30

Extramammary Paget's disease of scrotum--report of 25 cases and literature review. Urol Oncol (2008) 1.30

Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS. Proc Natl Acad Sci U S A (2009) 1.30

The localization and phosphorylation of p47 are important for Golgi disassembly-assembly during the cell cycle. J Cell Biol (2003) 1.29

WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs long-term memory. J Neurosci (2011) 1.29

Controllable disorder engineering in oxygen-incorporated MoS2 ultrathin nanosheets for efficient hydrogen evolution. J Am Chem Soc (2013) 1.28

Neuroanatomical phenotypes in the reeler mouse. Neuroimage (2006) 1.26

Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci (2005) 1.24

Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology (2004) 1.24

New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev (2012) 1.23

Structural insights into the p97-Ufd1-Npl4 complex. Proc Natl Acad Sci U S A (2007) 1.22

Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol Cell Biol (2005) 1.21

Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem (2006) 1.20

A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol (2010) 1.20

Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques. Med Phys (2012) 1.19

Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J Neurosci (2013) 1.19